"According to the latest report published by Data Bridge Market Research, the Chronic Depressive Personality Disorder Treatment Market The global chronic depressive personality disorder treatment market size was valued at USD 1.70 billion in 2024 and is expected to reach USD 2.90 billion by 2032, at a CAGR of 6.90% during the forecast period. The...

"Depression Screening Market Summary: According to the latest report published by Data Bridge Market Research, the Depression Screening Market Data Bridge Market Research analyses that the global depression screening market was valued at USD 10,624.91 million in 2022 and is further estimated to reach USD 15,829.87 million by 2030, and is expected to grow at a CAGR of 5.11% during...

The global healthcare landscape is undergoing a radical shift as software driven medical interventions move from the periphery to the center of clinical practice. The Digital Therapeutics (DTx) market is poised for exponential growth through 2028, driven by the increasing prevalence of chronic diseases, the necessity for cost effective healthcare delivery, and the rapid adoption of smartphone...

The Insomnia Therapeutics Market is gaining significant traction worldwide as sleep disorders become increasingly prevalent across all age groups. Valued at US$ 2,902.32 million in 2024, the market is projected to expand at a CAGR of 4.90% between 2025 and 2032. The rise in chronic stress, lifestyle-induced sleep disturbances, and growing awareness of mental health issues continues to fuel...

"Depression Screening Market Summary: According to the latest report published by Data Bridge Market Research, the Depression Screening Market Data Bridge Market Research analyses that the global depression screening market was valued at USD 10,624.91 million in 2022 and is further estimated to reach USD 15,829.87 million by 2030, and is expected to grow at a CAGR of 5.11% during...

Depressive disorders continue to represent a significant healthcare challenge across North America, with increasing prevalence rates influencing treatment demand, healthcare spending, and pharmaceutical innovation. Mental health conditions such as major depressive disorder, persistent depressive disorder, and treatment resistant depression are becoming more visible due to growing awareness...